You are here: Industry Insights > 2023

News List

Global top 20 Best-Selling Race of Medicine by 2023 Shruti Talashi
September 26, 2024
Top 20 medications by global sales list of 2023 was not without its surprises, given the year's significant patent expirations, the emergence of weight-loss medications, and other novel developments.
Inventory of New Drug Targets in 2023 roger
May 21, 2024
In 2023, 49 new drugs received their first approval in the United States, the European Union, and Japan.
Advancements in scientific technologies to Drug discovery and Development 2023 Shruti Talashi
January 02, 2024
Technological advancement apart from a deeper comprehension of disease biology, and an emphasis on breaking down conventional boundaries is driving this era of profound change in the drug development industry.
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused Shruti Talashi
January 02, 2024
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
New regulations in the Year 2023 for different regulatory bodies around the world Muhammad Asim Niazi
January 23, 2024
This article will explore new regulations in countries like the United States, Europe, Japan, and Australia.
Advancements in the field of synthetic biology in 2023 by ChatGPT ChatGPT
October 20, 2023
Synthetic biology is a multidisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems.
Pharmaceutical Business in China and Worldwide (October)(2023) PharmaSources
November 01, 2023
Pharmaceutical companies sign cooperation agreements with research laboratories to provide commercialization of drug products.
Drug Marketing in China and Worldwide (October)(2023) PharmaSources
November 01, 2023
Drugs have been approved for marketing, and some diseases have been treated.
Drug Marketing in China and Worldwide (September)(2023) PharmaSources
October 01, 2023
For the importance of disease monoclonal antibodies, the drug ingredient is still being tested.
Pharmaceutical Business in China and Worldwide (September)(2023) PharmaSources
October 01, 2023
Pharmaceutical companies reached a cooperation agreement and began to commercialize drugs for the treatment of diseases.